Drug Type Small molecule drug |
Synonyms BEBT 808, BEBT808 |
Target |
Mechanism GLP-1R agonists(Glucagon-like peptide 1 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | CN | 21 Aug 2023 | |
Diabetes Mellitus | Preclinical | CN | 11 Jul 2022 |